Autopsy report · NCT00319839
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab
Cause of deathSlow enrollment
“slow accrual”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 4 years 3 months before it stopped.
- 10 participants enrolled.
- Results were posted on the registry 7 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of California, Irvine
- Sponsor type
- University, hospital or other
- Conditions
- Head and Neck Cancer
- Interventions
- Abraxane; Cetuximab
- Participants
- 10
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.